| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCSG | Common Stock | Award | $13,442 | +889 | +5.2% | $15.12 | 18,091 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | HCSG | Common Stock | Options Exercise | $0 | +2,819 | +16% | $0.000000 | 20,910 | 03 Jan 2022 | Direct | |
| transaction | HCSG | Common Stock | Options Exercise | $0 | +1,930 | +9.2% | $0.000000 | 22,840 | 04 Jan 2022 | Direct | |
| transaction | HCSG | Common Stock | Options Exercise | $0 | +1,200 | +5.3% | $0.000000 | 24,040 | 04 Jan 2022 | Direct | |
| transaction | HCSG | Common Stock | Options Exercise | $0 | +1,700 | +7.1% | $0.000000 | 25,740 | 04 Jan 2022 | Direct | |
| transaction | HCSG | Common Stock | Options Exercise | $0 | +2,002 | +7.8% | $0.000000 | 27,742 | 04 Jan 2022 | Direct | |
| transaction | HCSG | Common Stock | Tax liability | $0 | -3,770 | -14% | $0.000000 | 23,972 | 04 Jan 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCSG | Phantom Stock | Award | $27,219 | +1,530 | +23% | $17.79 | 8,189 | 03 Jan 2022 | Common Stock | 1,530 | Direct | F3, F4 | |
| transaction | HCSG | Restricted Stock Units | Options Exercise | $0 | -2,819 | -25% | $0.000000 | 8,450 | 03 Jan 2022 | Common Stock | 2,819 | Direct | F3, F5 | |
| transaction | HCSG | Stock Option (right to buy) | Award | $669,229 | +36,974 | $18.10 | 36,974 | 04 Jan 2022 | Common Stock | 36,974 | $18.10 | Direct | F6 | |
| transaction | HCSG | Restricted Stock Units | Award | $0 | +16,587 | $0.000000 | 16,587 | 04 Jan 2022 | Common Stock | 16,587 | Direct | F3, F7 | ||
| transaction | HCSG | Restricted Stock Units | Options Exercise | $0 | -1,930 | -100% | $0.000000* | 0 | 04 Jan 2022 | Common Stock | 1,930 | Direct | F3, F8 | |
| transaction | HCSG | Restricted Stock Units | Options Exercise | $0 | -1,200 | -50% | $0.000000 | 1,200 | 04 Jan 2022 | Common Stock | 1,200 | Direct | F3, F9 | |
| transaction | HCSG | Restricted Stock Units | Options Exercise | $0 | -1,700 | -33% | $0.000000 | 3,400 | 04 Jan 2022 | Common Stock | 1,700 | Direct | F3, F10 | |
| transaction | HCSG | Restricted Stock Units | Options Exercise | $0 | -2,002 | -20% | $0.000000 | 8,009 | 04 Jan 2022 | Common Stock | 2,002 | Direct | F3, F11 |
| Id | Content |
|---|---|
| F1 | The original Form 4, filed on January 5, 2022, is being amended solely to correct Mr. Shea's officer title in box 5. As announced on August 24, 2021, Mr. Shea was appointed EVP & Chief Administrative Officer. |
| F2 | Acquired by the Reporting Person through participation in the Healthcare Services Group, Inc. Employee Stock Purchase Plan. |
| F3 | Shares issued at the conversion rate of 1-for-1. |
| F4 | Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer. |
| F5 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2020 grant date. |
| F6 | These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date. |
| F7 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date. |
| F8 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date. |
| F9 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2018 grant date. |
| F10 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2019 grant date. |
| F11 | These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2021 grant date. |